de Philippis, C., Legrande, F., Bramanti, S., Montes de Oca, C., Dulery, R., Bouabdallah, R., Granada, A., Devillier, R., Mariotti, J., Sarina, B., Harbi, S., Maisano, V., Furst, S., Pagliardini, T., Weiller, P., Lemarie, C., Calmels, B., Chabannon, C., Carlo‐Stella, C., Santoro, A., Mohty, M., Blaise, D., & Castagna, L. (n.d.). cHECKPOINT INHIBITION BEFORE HAPLOIDENTICAL TRANSPLANTATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA PATIENTS IS ASSOCIATED WITH HIGHER PFS WITHOUT INCREASED TOXICITIES. Hematological oncology, 37, 298–299. http://access.bl.uk/ark:/81055/vdc_100086207390.0x000041